Hagar Sonego

464 total citations
9 papers, 357 citations indexed

About

Hagar Sonego is a scholar working on Cellular and Molecular Neuroscience, Physiology and Molecular Biology. According to data from OpenAlex, Hagar Sonego has authored 9 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cellular and Molecular Neuroscience, 3 papers in Physiology and 2 papers in Molecular Biology. Recurrent topics in Hagar Sonego's work include Neuroscience and Neuropharmacology Research (3 papers), Alzheimer's disease research and treatments (3 papers) and Reproductive Physiology in Livestock (2 papers). Hagar Sonego is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Alzheimer's disease research and treatments (3 papers) and Reproductive Physiology in Livestock (2 papers). Hagar Sonego collaborates with scholars based in Israel. Hagar Sonego's co-authors include Rachel Brandeis, Zipora Pittel, Niva Natan, Abraham Fisher, Rachel Haring, Nira Bar-Ner, Rina Meidan, D. Wolfenson, Lily Raveh and M. Kaim and has published in prestigious journals such as Annals of the New York Academy of Sciences, Annals of the Rheumatic Diseases and Reproduction.

In The Last Decade

Hagar Sonego

8 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hagar Sonego Israel	8	127	99	98	84	67	9	357
P. Évrard Belgium	13	142 1.1×	63 0.6×	62 0.6×	64 0.8×	19 0.3×	33	469
S. Striem Israel	13	66 0.5×	98 1.0×	96 1.0×	38 0.5×	92 1.4×	16	550
Sutthasinee Poonyachoti Thailand	11	106 0.8×	35 0.4×	128 1.3×	68 0.8×	11 0.2×	34	404
Verónica Gutiérrez Uruguay	13	449 3.5×	124 1.3×	132 1.3×	121 1.4×	35 0.5×	35	1.0k
Angela Patricia López‐Cardona Spain	12	131 1.0×	100 1.0×	53 0.5×	64 0.8×	33 0.5×	17	428
Jeffrey A. Doebler United States	12	154 1.2×	72 0.7×	85 0.9×	84 1.0×	7 0.1×	44	445
Kjell Malmlöf Denmark	15	133 1.0×	55 0.6×	38 0.4×	163 1.9×	25 0.4×	46	641
M. Wolff Germany	11	185 1.5×	25 0.3×	66 0.7×	49 0.6×	7 0.1×	18	552
Sussy Bastías‐Candia Chile	9	172 1.4×	25 0.3×	88 0.9×	76 0.9×	14 0.2×	13	356
Martin Br United States	8	130 1.0×	164 1.7×	133 1.4×	52 0.6×	19 0.3×	18	390

Countries citing papers authored by Hagar Sonego

Since Specialization

Citations

This map shows the geographic impact of Hagar Sonego's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hagar Sonego with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hagar Sonego more than expected).

Fields of papers citing papers by Hagar Sonego

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hagar Sonego. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hagar Sonego. The network helps show where Hagar Sonego may publish in the future.

Co-authorship network of co-authors of Hagar Sonego

This figure shows the co-authorship network connecting the top 25 collaborators of Hagar Sonego. A scholar is included among the top collaborators of Hagar Sonego based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hagar Sonego. Hagar Sonego is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Torrent, Anna, E. Montell, Josep Vergés, et al.. (2014). SAT0547 Chondroprotective Activity of Acti-Joint®, A Combination of Chondroitin Sulphate, Glucosamine and A Natural Ingredient Rich in Hyaluronic Acid. Annals of the Rheumatic Diseases. 73. 789–789.

Aharoni, Rina, Hagar Sonego, Ori Brenner, Raya Eilam, & Ruth Arnon. (2007). The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells. Immunology Letters. 112(2). 110–119. 30 indexed citations

Weissman, Ben Avi, Rachel Brandeis, Eran Gilat, et al.. (2004). Monitoring Drug‐Induced Neurodegeneration by Imaging of Peripheral Benzodiazepine Receptors. Annals of the New York Academy of Sciences. 1025(1). 584–589. 12 indexed citations

Fisher, Abraham, Zipora Pittel, Rachel Haring, et al.. (2003). M<sub>1</sub> Muscarinic Agonists Can Modulate Some of the Hallmarks in Alzheimer's Disease: Implications in Future Therapy. Journal of Molecular Neuroscience. 20(3). 349–356. 116 indexed citations

Fisher, Abraham, et al.. (2002). AF150(S) and AF267B. Journal of Molecular Neuroscience. 19(1-2). 145–153. 60 indexed citations

Raveh, Lily, Ben Avi Weissman, Giora Cohen, et al.. (2002). Caramiphen and Scopolamine Prevent Soman-Induced Brain Damage and Cognitive Dysfunction. NeuroToxicology. 23(1). 7–17. 55 indexed citations

Fisher, Abraham, Rachel Brandeis, Rachel Haring, et al.. (2002). Impact of muscarinic agonists for successful therapy of Alzheimer’s disease. Journal of neural transmission. Supplementum. 189–202. 11 indexed citations

Wolfenson, D., et al.. (2002). Seasonal differences in progesterone production by luteinized bovine thecal and granulosa cells. Domestic Animal Endocrinology. 22(2). 81–90. 60 indexed citations

Wolfenson, D., et al.. (1999). Comparison of the steroidogenic capacity of bovine follicular and luteal cells, and corpora lutea originating from dominant follicles of the first or second follicular wave. Reproduction. 117(2). 241–247. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact